3、LiuY, Huang Q, Liu W, Liu Q, Jia W, Chang E, Chen F, Liu Z, Guo X, Mo H, Chen J,Rao D, Ye W, Cao S*, Hong M.Establishment of VCA and EBNA1 IgA-based combination by enzyme-linkedmmunosorbent assay as preferred screening method for nasopharyngeal carcinoma:a two-stage design with a preliminary performance study and a mass screening insouthern China. IntJ Cancer. 2011 Aug 22. doi: 10.1002/ijc.26380. [Epub ahead of print]
5、Cao SM, Liu Z, Jia WH, Huang QH, Liu Q, Guo X, HuangTB, Ye W, Hong MH. Fluctuations of Epstein-Barr VirusSerological Antibodies and Risk for Nasopharyngeal Carcinoma: A ProspectiveScreening Study with a 20-Year Follow-Up. PLoS One. 2011,6(4):e19100.
6、SuMeiCao*, Malcolm J. Simons, ChaoNan Qian.The prevalence and prevention of nasopharyngeal carcinoma in China.Chinese Journal of Cancer(癌症). 2011, 30(2), 114-119
7、SuMei Cao,JieKaiYu, QiuYan Chen, et al. Detection of nasopharyngeal carcinomausing surfaceenhanced laser desorption and ionization mass spectrometryprofiles of the serum proteome. Chinese Journalof Cancer(癌症). 2010, 29(8):721-728
8、Lv X, Xiang YQ, Cao SM,Qian CN, Li NW, Guo L, Mai HQ, Chen QY, Huang PY, Luo D, Cao KJ, Hong MH, GuoX.Prospective validation of the prognostic value of elevatedserum vascular endothelial growth factor in patients with nasopharyngeal carcinoma:More distant metastases and shorter overall survival after treatment. Head Neck. 2010 Oct 21. [Epub ahead ofprint]